Fast facts
FACT vs. FICTION of the India Glivec patent case
It is difficult to look objectively at intellectual property rights and access to medicines. Certain facts, however, are not debated.
History of Glivec in India
Key milestones for Glivec, Indian patent law formation and this case are outlined in the History of Glivec in India fact sheet.
GIPAP in India
GIPAP is one of the largest global patient assistance programs ever launched, and 43% of participants are in India. More details are available in the GIPAP in India fact sheet.
Patents explained
What is a patent? What rights does a patent-holder have? Read what the World Intellectual Property Organization has to say about patent protection.
Novartis in India
A brief look at the Novartis India offices is available in the Novartis in India fact sheet.
Our voice in India
Novartis patient assistance in India from the perspective of the head of MaxStation India
Patient testimonials
'Thanks to Glivec, I can take part in the next Olympic games'
Novartis Links on India Glivec® Patent Case
Novartis Perspective
(40KB)
Novartis Open Letter to Organizations
(106KB)
Frequently Asked Questions
(76KB)
Key Terms Glossary
(75KB)